細胞浸透性オリゴヌクレオチド-オリゴスペルミン結合体による遺伝子発現のアンチセンセと抗原阻害
Keith T Gagnon1, Jonathan K Watts, Hannah M Pendergraff
1Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Journal of the American Chemical Society
|May 5, 2011
まとめ
Zip核酸 (ZNA) は,新しいオリゴヌクレオチド-オリゴスペルミン結合体であり,細胞伝達における課題を克服します. これらのZNAは,低濃度でアンチセンセと抗原剤として,遺伝子発現を効果的に沈黙させます.
科学分野:
- 分子生物学は分子生物学である.
- 遺伝子発現の規制について
- オリゴヌクレオチドの治療薬
背景:
- オリゴヌクレオチドは遺伝子調節のために確立されていますが,顔の配達と細胞の吸収は,負の電荷があるため,ハードルです.
- 効果的な投与戦略の開発は,オリゴヌクレオチドベースの治療法の進歩に不可欠です.
- 特定の遺伝子配列をターゲットにするには,効率的な細胞内アクセスと認識が必要です.
研究 の 目的:
- オリゴヌクレオチド-オリゴスペルミン結合体 (ZNAs) を,強化された遺伝子サイレンシングのためのソリューションとして調査する.
- アンチセンセと抗原剤の両方としてのZNAの有効性を評価する.
- ZNAsのキャリアフリー細胞吸収と遺伝子調節能力を実証する.
主な方法:
- DNAとロックされた核酸 (LNA) オリゴヌクレオチドを含むZNA結合体の合成.
- キャリアなしのナノモラー濃度でのZNA細胞吸収の評価.
- アンチセンセスの活動のためのハンティングチン (HTT) mRNAを標的とするZNAの適用.
- 抗原活性のためのプロゲステロン受容体 (PR) プロモーターをターゲットにするためにZNAを使用する.
主要な成果:
- オリゴスペルミン結合は,ナノモラー濃度でのオリゴヌクレオチドのキャリアフリー細胞吸収を大幅に改善しました.
- ZNA結合体は強力な遺伝子静止効果を示し,効果的な反感覚および抗原剤として作用した.
- HTT mRNAをZNAにターゲティングすることで,突然変異したハンティングチンのタンパク質発現を選択的に抑制した.
- PRプロモーターを標的としたZNAは,プロゲステロン受容体発現を成功裏に阻害しました.
結論:
- ZNA結合体は,オリゴヌクレオチド配送の課題を克服するための有望な戦略を表しています.
- ZNAは,治療用途の汎用性のある遺伝子サイレンス剤として大きな可能性を秘めています.
- 新しい遺伝子調節療法として開発するために,ZNA結合体のさらなる研究が必要である.
関連する概念動画
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...

